Ownership history in ROYCE & ASSOCIATES LP · 15 quarters on record
This page tracks every 13F SEC filing in which ROYCE & ASSOCIATES LP reported a position in LIFEMD INC (LFMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 909,651 | +95,200 | +11.7% | 0.03% | $3.1M | $3.41 |
| 2025 Q3 | ADDED | 814,451 | +44,000 | +5.7% | 0.06% | $5.5M | $6.79 |
| 2025 Q2 | REDUCED | 770,451 | -384,780 | -33.3% | 0.11% | $10.5M | $13.62 |
| 2025 Q1 | ADDED | 1,155,231 | +39,240 | +3.5% | 0.07% | $6.3M | $5.44 |
| 2024 Q4 | ADDED | 1,115,991 | +214,950 | +23.9% | 0.05% | $5.5M | $4.95 |
| 2024 Q3 | ADDED | 901,041 | +114,710 | +14.6% | 0.04% | $4.7M | $5.24 |
| 2024 Q2 | REDUCED | 786,331 | -15,264 | -1.9% | 0.05% | $5.4M | $6.86 |
| 2024 Q1 | REDUCED | 801,595 | -31,031 | -3.7% | 0.07% | $8.2M | $10.28 |
| 2023 Q4 | REDUCED | 832,626 | -263,882 | -24.1% | 0.06% | $6.9M | $8.29 |
| 2023 Q3 | ADDED | 1,096,508 | +76,426 | +7.5% | 0.07% | $6.9M | $6.25 |
As of 2025 Q4 — sorted by position size